about
Aberrant insulin signaling in Alzheimer's disease: current knowledgeAltered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice.The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin.Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion.Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.Data available on the extent of cocaine use and dependence: biochemistry, pharmacologic effects and global burden of disease of cocaine abusers.Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function.Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient miceGenetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats.Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects.Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorderShort- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases.The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease.Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease.Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal.Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.From Obesity Resistance to Obesity Prediction and Prevention?Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [(13)C2D4]RAD001 internal standard.Editorial: Dysmetabolism, Obesity, and Inflammation: Three Prominent Actors in the Drama of Major Neuropsychiatric DisordersDifferential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease.Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures.Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors.Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC.Striatal 6-OHDA lesion in mice: Investigating early neurochemical changes underlying Parkinson's disease.Olfactory memory is impaired in a triple transgenic model of Alzheimer disease.Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levels.Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels.Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats.Antinutritional effects of fumonisin B1 and pathophysiological consequences.The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat.Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
P50
Q27024222-95ECC9ED-8BAF-40A5-8348-00F11504BB6FQ30463124-1E97C81C-4FF3-4E5A-93DF-30156121008FQ33975720-9516C0AD-33F4-4276-B7AD-84527C4209CCQ34181056-D7257FF0-0D5C-4781-891E-627014D8CADDQ34234907-242CAEF0-68CA-4287-8D95-235F84D78F8AQ34291945-F776701A-2C15-403A-AC04-D069D1B362F5Q34563067-468439C9-115A-4089-A3AD-D0B67BD17475Q34608846-F28EA9F7-EBF7-47F8-A434-4751CFDB993FQ34660430-B6598ED2-B408-4492-B8EA-561E26249DEBQ34680801-BFD3BE18-A8C5-4806-A4B5-A471E774C980Q34992627-662F8D0B-6617-408C-AD33-3B8DC2B4EB25Q35070472-4D604751-B8BF-43B3-8AF6-6B80BF25F6D3Q35179010-C606D69C-8042-4B1E-8A7B-CF10919E4062Q36248857-04569431-57C8-449B-B87C-86180BD5C1F3Q36287901-C6E33931-8996-4C16-BD1B-5EF7166B7342Q36949345-5F270D4E-E2B2-48E1-88CB-66A4F834C4DEQ37522043-5C1EB4B7-FEF5-4389-AFAA-95C8033B152DQ37896112-D545DC62-A7EB-4107-A87C-44795DC494B5Q38242149-430BC2E4-DE90-45F9-815C-3EC041F8F467Q38809514-6D9DAEB1-CE8C-4E0E-B895-BD09E1AAC95FQ39055876-F24FB6CD-A55D-403E-85C3-2989D217641CQ39073552-C464DD57-209D-48B8-939B-5F71C0F31139Q40055069-B982B63C-D702-4330-A5F7-D9D502D7A8F3Q42127229-A2DD6C69-E2A8-4AEA-8919-BF846FE42E37Q42164941-7F864D65-9691-4D1F-8111-A20345448A69Q42346355-B53E47B4-515D-4927-B7C0-D2D3F3A3443FQ42474130-61445512-DFF0-4E7A-A699-AD19DF03AEBBQ42496705-43829D94-AA69-4328-A6C1-C2EBAFC97857Q42496867-A505E03D-E984-471A-8847-1B81FF49C69BQ42520957-5F97E85E-5736-473B-9FFA-869F50DB0374Q43234962-F5E6B054-0AF1-4019-8768-28C9DBBCDE5AQ43242127-2AC91EFF-CA6E-4248-A130-B1C04A38DCE0Q43331593-575352FB-BF0B-488E-9F7F-CC0ACD0E6EA1Q43698314-98418BCB-6C94-4C2D-A4CC-861EC8456489Q43760360-896161FC-BB80-4811-AAC9-D74ACD4700F9Q43854208-70304FD8-B7AF-4815-B35A-D99B67D93652Q44391014-E5009793-AA66-411F-A9F3-879162DA6317Q44897754-E392BDA7-5AE1-4C1D-9A9C-A9ADAF20DA40Q45927862-52BCB37F-3A15-4444-A509-D94A491E75FBQ46126467-91282BBD-0604-4224-874D-7D806CEF3931
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tommaso Cassano
@ast
Tommaso Cassano
@en
Tommaso Cassano
@es
Tommaso Cassano
@nl
Tommaso Cassano
@sl
type
label
Tommaso Cassano
@ast
Tommaso Cassano
@en
Tommaso Cassano
@es
Tommaso Cassano
@nl
Tommaso Cassano
@sl
altLabel
TOMMASO CASSANO
@en
prefLabel
Tommaso Cassano
@ast
Tommaso Cassano
@en
Tommaso Cassano
@es
Tommaso Cassano
@nl
Tommaso Cassano
@sl
P106
P1153
7004394578
P21
P31
P496
0000-0001-6330-806X